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Summary 
The importance of extracellular traps (ETs) in innate immunity is well established, but 
the molecular mechanisms responsible for their formation remain unclear and in 
scientific dispute. ETs have been defined as extracellular DNA scaffolds associated 
with the granule proteins of eosinophils or neutrophils. They are capable of killing 
bacteria extracellularly. Based mainly on results with phosphoinositide 3-kinase 
(PI3K) inhibitors such as 3-methyladenine (3-MA) and wortmannin which are 
commonly used to inhibit autophagy, several groups have reported that autophagy is 
required for neutrophil extracellular trap (NET) formation. We decided to investigate 
this apparent dependence on autophagy for ET release and generated genetically 
modified mice that lack, specifically in eosinophils or neutrophils, autophagy-related 
(Atg) 5, a gene encoding a protein essential for autophagosome formation. 
Interestingly, neither eosinophils nor neutrophils from Atg5-deficient mice exhibited 
abnormalities in ET formation upon physiological activation or exposure to low 
concentrations of PMA, although we could confirm that human and mouse 
eosinophils and neutrophils, after pre-treatment with inhibitors of class III PI3K, show 
a block both in reactive oxygen species (ROS) production and in ET formation. The 
so-called late autophagy inhibitors bafilomycin A1 and chloroquine, on the other 
hand, were without effect. These data indicate that ET formation occurs 
independently of autophagy and that the inhibition of ROS production and ET 
formation in the presence of 3-MA and wortmannin is likely owing to their additional 
ability to block the class I PI3Ks which are involved in signaling cascades initiated by 
triggers of ET formation. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Keywords: Autophagy; extracellular traps (ETs); eosinophils; neutrophils; neutrophil 
extracellular traps (NETs). 
 
Introduction 
Extracellular DNA traps can be generated by several different leukocytes, including 
neutrophils, eosinophils, basophils, and monocytes, as well as mast cells,1 whereby 
neutrophil extracellular traps (NETs) have been most frequently studied. 
Extracellular DNA traps can bind and kill microorganisms in the extracellular space,2 
and most investigators agree that NETs contribute significantly to innate immunity 
and, in fact, are seen in vivo with many infectious, allergic, and autoimmune 
diseases. The molecular mechanisms responsible for their formation remain unclear 
and in dispute.3 Several groups have reported a requirement for autophagy in the 
formation of extracellular traps (ETs). The majority of these reports have used 
pharmacological approaches to demonstrate that inhibition of the 
phosphatidylinositol 3-kinase (PI3K) type III signaling, which is required for 
autophagosome formation, prevents NET formation, implying a role for autophagy in 
NET formation.4-6 Moreover, controversial findings have been reported regarding the 
effect of mTOR on the kinetics of NET formation; both inhibitory and potentiating 
effects have been observed.7,8 Very recently it has been suggested that aging-
related ATG5 defects might impair NET formation.9 
 
Autophagy is a cellular mechanism responsible for the turnover of 
macromolecules and organelles via the lysosomal degradative pathway. Cells 
usually respond with the induction of autophagy following stress.10 Using wortmannin 
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as an inhibitor of class III PI3K to block phorbol 12-myristate 13-acetate (PMA)-
induced NET formation, Remijsen et al. (2011) reported that autophagy has a key 
role in NET formation.5 It is important to note that wortmannin can also completely 
inhibit reactive oxygen species (ROS) production in human neutrophils following 
zymosan, hydrocarbon, TNF-, or adhesion receptor stimulation.11-15 Furthermore, 3-
methyladenine (3-MA), another inhibitor of class III PI3K, has been shown to reduce 
ROS production in activated neutrophils just as efficiently as diphenylene iodonium 
(DPI), a potent inhibitor of ROS production.13,16 Since ROS has been shown to be 
essential for NET formation2,17 and to be a trigger for autophagy,18 we addressed the 
question whether autophagy has a direct role in ET formation by silencing Atg5 in 
both eosinophils and neutrophils. Its product, ATG5, is required for autophagy, 
playing an early role in phagophore development and especially in autophagosome 
elongation.10 
 
To this end, we generated mice in which Atg5 can be conditionally deleted in 
eosinophils (hereafter designated Atg5eoΔ mice) or in neutrophils (hereafter 
designated Atg5NΔ mice19). Data obtained in ATG5-knockout granulocytes were 
compared with data from experiments in which pharmacological inhibitors of 
autophagy were employed in normal mouse and human eosinophils and neutrophils. 
We report here that ET formation is an autophagy-independent process in both 
eosinophils and neutrophils. 
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Methods 
Reagents 
Human granulocyte/macrophage colony-stimulating factor (GM-CSF) was purchased from Novartis 
Pharma GmbH (Nürnberg, Germany). Mouse GM-CSF and human IL-5 were purchased from R&D 
Systems (Abingdon, UK). Human and mouse C5a were from Hycult Biotech (Uden, The Netherlands). 
German glass coverslips (#1 thickness, 12 mm diameter) were obtained from Karl Hecht GmbH & Co. 
KG "Assistent", Sondheim/Rhön, Germany. Black, glass-bottom 96-well plates were from Greiner Bio-
One GmbH (Frickenhausen, Germany). Lipopolysaccharide (LPS, 055:B5), dihydrorhodamine-123 
(DHR123) and saponin were from Sigma-Aldrich (Buchs, Switzerland). PMA was from Merck 
Millipore, Zug, Switzerland. DNase I was purchased from Worthington Biochemical Corporation 
(Lakewood, NJ, USA). The Quant-iT
TM
PicoGreen
®
dsDNA Assay Kit, MitoSOX Red, propidium iodide 
(PI), Prolong Gold mounting media and Hoechst 33342 were from ThermoFisher Scientific (distributed 
by LuBioScience GmbH, Lucerne, Switzerland). X-VIVO™ 15 medium and Medium 199, containing L-
glutamine, HEPES and 1.4 g/l NaHCO3, were from Lonza (Walkersville, MD, USA). The protease 
inhibitor cocktail was from Roche Diagnostics (Rotkreuz, Switzerland). Polyvalent human IgG was a 
kind gift from CSL Behring (Bern, Switzerland). Normal goat serum was from Santa Cruz 
Biotechnology, Inc. (Heidelberg, Germany). ChromPure human IgG was obtained from Milan 
Analytica AG (Rheinfelden, Switzerland).  
 
Atg5
NΔ
 mice  
All animal studies were approved by the Cantonal Veterinary Office of Bern, Switzerland. Atg5
flox/flox
 
mice
20
 were kindly provided by Dr. Christian Münz (University of Zurich, Switzerland). Lyz2
Cre/Cre 
mice 
(B6.129P2-Lyz2tm1(cre)Ifo) were purchased from Jackson Laboratories (Bar Harbor, ME, USA) at 
backcross generation N6 and were further backcrossed to N10 with C57BL6/J mice. Atg5
flox/flox 
were 
crossed with Lyz2
Cre/Cre 
mice to obtain Atg5
flox/flox
-Lyz2
Cre/Cre 
(Atg5
NΔ
) mice. Mice were genotyped as 
described.
19
 
Atg5
eoΔ
 mice 
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The Epx-Cre (eoCRE) strain (kindly provided by Dr. J.J. Lee, Mayo Clinic, Scottsdale, Arizona, USA) 
generated by homologous recombination in embryonic stem cells was used to create a knock-in strain 
of mice (eoCRE) Epx
tm1.1(cre)Jlee
/Epx
+
Gt(ROSA)26Sor
tm1(DTA)Lky
/Gt(ROSA)26Sor
+
 with a chimeric locus 
that encodes a mammalianized Cre recombinase from the endogenous AUG start codon of the Epx 
ORF on a C57BL/6J background. The eoCRE strain in conjunction with strains of mice carrying floxed 
genes of interest permits eosinophil lineage-specific targeting of gene expression. It expresses Cre 
from the open reading frame of the endogenous gene encoding eosinophil peroxidase (Epx) and thus 
expresses Cre only after commitment to the eosinophil lineage and is exceedingly specific for 
eosinophils rather than cells of other hematopoietic lineages.
21
 Enzymatic and ELISA data derived 
from hemizygous or homozygous eoCRE mice showed that the IRES element was insufficient to 
rescue EPX expression from the knock-in locus. Thus, all subsequent studies described here were 
performed with eoCRE hemizygous mice that displayed EPX expression levels within a factor of two 
of wild-type C57BL/6J animals. Hemizygous experimental eoCRE mice were generated by crossing of 
homozygous or hemizygous eoCRE mice with wild-type C57BL/6J animals. Hematological 
examinations (i.e., cell counts and differentials) of eoCRE mice demonstrated that the baseline levels 
of circulating leukocytes in these knock-in animals were unaffected relative to wild-type.
21
 Atg5
flox/flox 
mice were crossed with eoCRE mice to generate Atg5
eoΔ
 mice.  
 
IL5
tg
_Atg5
eoΔ
 mice 
To increase number of eosinophils in functional in vitro assays, we generated IL5
tg
_Atg5
eoΔ
 mice by 
crossing IL-5
tg
 (C57BL/6J-Tg(Il5)1638Jlee) (kindly provided by Dr. J.J. Lee) and Atg5
eoΔ
 mice. Control 
mice (IL5
tg
_Atg5
flox/flox 
) were generated by crossing IL-5
tg 
mice with
 
Atg5
flox/flox
. 
 
Purification of mouse neutrophils and eosinophils 
Lyz2
Cre/Cre 
and Atg5
N∆
 mice were analyzed either between 8 and 12 weeks of age. In additional 
experiments, mice were between 9 and 10 months old. Primary bone marrow mouse neutrophils were 
isolated from control and Atg5
NΔ
 mice
19
 under animal license BE54/15, by a negative selection 
technique using an EasySep Mouse Neutrophil Enrichment Kit (Stemcell Technologies, Grenoble, 
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France). Briefly, bone marrow cells were collected by flushing the femur with 5 ml of isolation medium 
(PBS plus 2% FCS, no EDTA added) using a 26-gauge needle and filtering through a sterile 70-µM 
nylon cell strainer. Bone marrow single-cell suspensions were then washed with medium and the cells 
counted with a hemocytometer using the Türk’s staining solution (Merck Millipore). Primary bone 
marrow neutrophils were then isolated by a negative selection technique using the EasySep Mouse 
Neutrophil Enrichment Kit (Stemcell Technologies) and the isolation medium described above. Mouse 
neutrophil purity was higher than 93% as assessed by staining with the Hematocolor Set (Merck 
Millipore) followed by light microscopic analysis.
19
 
Mouse eosinophils were isolated from IL5
tg
_Atg5
flox/flox 
and IL5
tg
_Atg5
eoΔ
 mice, aged between 
8 and 12 weeks. For eosinophils isolation, bone marrow cells were collected by flushing the femurs 
and tibia with medium (2% FCS in PBS), using a 26-gauge needle, and filtering through a sterile 70-
µM nylon cell strainer. Erythrocytes were lysed for 5 min by adding 3 ml of lysis buffer (155 mM 
NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA, pH 7.3). T cells, B cells, macrophages and neutrophils 
were depleted with antibodies against CD8α, CD19, CD90.2 and Ly-6G (Miltenyi Biotec, Bergisch 
Gladbach, Germany), using an EasySep Mouse PE Positive Selection Kit (Stemcell Technologies). 
Mouse eosinophil purity was higher than 95% as assessed by staining with the Hematocolor Set 
(Merck Millipore) followed by light microscopic analysis.
22
 
 
Purification of human neutrophils and eosinophils 
Written, informed consent was obtained from all blood donors. The Ethics Committee of the Canton of 
Bern approved this study. Human blood neutrophils were purified from healthy individuals by Ficoll-
Hypaque centrifugation as previously described.
23
 Briefly, peripheral blood mononuclear cells (PBMC) 
were separated by centrifugation on Pancoll Human from PAN
TM 
BioTech (PAN-Biotech GmbH, 
Aidenbach, Germany). The lower layer, consisting mainly of granulocytes and erythrocytes, was 
treated with erythrocyte lysis solution (155 mM NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA, pH 7.3). 
The resulting cell populations contained >95% neutrophils as assessed by staining with the 
Hematocolor Set followed by light microscopic analysis.  
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For eosinophil isolation, white blood cells were isolated from Lithium-heparinized blood of 
healthy donors by Ficoll (Biocoll, Biochrom AG) density gradient centrifugation and magnetic beads 
as previously described.
22
 Blood was diluted with PBS, layered onto Ficoll and the PBMC were 
separated from granulocytes/erythrocytes by centrifugation at 800 x g. Erythrocytes were lysed with 
lysis solution (155 mM NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA, pH 7.3) to obtain granulocytes. 
Eosinophils were isolated with kit from Stemcell Technologies. Purity of eosinophils was assessed by 
Diff-Quik staining and light microscopy and was > 97%. 
 
Immunoblotting 
Protein expression was analyzed by immunoblotting. 1-5 x 10
6
 cells were washed with PBS and lysed 
in modified RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton-X100, 0.5% Na-
deoxycholate, 0.1% SDS, 2 mM EDTA supplemented with 0.5 mg/ml pepstatin A and complete 
protease inhibitor cocktail). Protein concentrations were determined by BCA protein assay 
(ThermoFisher Scientific) and samples denatured in reducing Laemmle buffer prior to separation by 
SDS/PAGE gel electrophoresis. Proteins were blotted on PVDF transfer membrane (Merck Millipore, 
MA, USA) and subsequently probed with the following primary antibodies: mouse anti-ATG5 
monoclonal antibody clone 7C6 (1:1000; Nanotools, catalogue number #0262-100), rabbit anti-p62 
polyclonal antibody (1:1000; Novus Biologicals LLC, CO, USA, catalogue number #NBP1-48320), 
rabbit anti-LC3B polyclonal antibody (1:1000; Novus Biologicals LLC, catalogue number #NB600-
1384) or mouse anti-GAPDH monoclonal antibody clone 6C5 (1:5000; Merck Millipore, catalogue 
number #MAB374). Secondary antibodies coupled to horseradish peroxidase were from GE 
Healthcare Life Sciences (distributed by VWR International GmbH, Dietikon, Switzerland) and signals 
detected by enhanced chemiluminescence (ECL Western blotting substrate, ThermoFisher Scientific) 
on photosensitive film (ECL Hyperfilm, GE Healthcare Life Sciences). 
 
Cell activation and confocal laser scanning microscopy 
Isolated neutrophils or eosinophils were resuspended in X-VIVO™ 15 medium (2.5 x 10
6
 /ml) and pre-
incubated for 30 min in presence or absence of inhibitors; 3-MA (5 mM), wortmannin (100 nM), 
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chloroquine (CQ) (10 µM), bafilomycin A1 (Baf A1) (250 nM) or rapamycin (1 µM). Cells were primed 
with 25 ng/ml GM-CSF for 20 min on untreated glass coverslips, which had previously been washed 
with acetone, ethanol, ddH2O, and baked in a high temperature (200°C) oven for 1 h. Cells were 
subsequently stimulated with 10
-8 
M C5a or 100 ng/ml LPS. Unprimed neutrophils were also incubated 
with 25 nM PMA for 15 min. Cells were then fixed with 4% paraformaldehyde for 5 min, subsequently 
washed three times in PBS (pH 7.4), stained with 1 μg/ml Hoechst 33342 and mounted in ProLong 
Gold mounting medium. For extracellular DNA detection, staining with cell permeable fluorescent 
dyes, such as MitoSox Red (5 μM), was performed with live cells prior to fixation according to the 
corresponding manufacturers’ instructions. 
Neutrophil elastase or eosinophil peroxidase (EPX) co-localization with extracellular DNA was 
analyzed by indirect immunofluorescence as previously described.
23,24
 Briefly, cells were fixed with 
4% paraformaldehyde and permeabilized with 0.05% saponin. Monoclonal mouse antibody to human 
neutrophil elastase (1:1000, clone NP57; Dako, Baar, Switzerland, catalogue number #M0752) or 
mouse anti-human EPX (1:100, clone MM25-82.2; obtained from Lee Laboratories, Mayo Clinic, 
Scottsdale, Arizona, USA) served as primary antibodies. Alexa Fluor® 488 conjugated secondary 
antibody was from ThermoFisher and used at 1:400. In these experiments, cells were stained with 10 
μg/ml PI for extracellular DNA detection. Slides were examined and images acquired by LSM 700 
(Carl Zeiss Micro Imaging, Jena, Germany) using a 63x /1.40 Oil DIC objective and followed by 
analysis with Imaris software (Bitplane AG, Zurich, Switzerland) as previously reported.23  
 
Quantification of released dsDNA in culture supernatants 
Released dsDNA was quantified as previously described.
23
 Briefly, 2 x 10
6
 isolated neutrophils or 
eosinophils in 500 l of medium (X-VIVO™ 15 for neutrophils, and Medium 199 for eosinophils) were 
stimulated as described above. At the end of the incubation time, a low concentration of DNase I (2.5 
U/ml; Worthington) was added for an additional 10 min, and proteinase K (0.2 mg/ ml; Roche) was 
added at the same time to eosinophils only. Reactions were stopped by addition of 2.5 mM EDTA, pH 
8.0. Cells were centrifuged at 500 x g for 5 min. 100 l supernatant was transferred to black, glass-
bottom 96-well plates (Greiner Bio-One GmbH) and the fluorescent activity of PicoGreen dye bound 
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to dsDNA was excited at 502 nm and the fluorescence emission intensity was measured at 523 nm 
using a spectrofluorimeter (SpectraMax M2, Molecular Devices, Biberach an der Riß, Germany), 
according to the instructions described in the Quant-iT
TM
PicoGreen
®
 Assay Kit.  
 
Reactive oxygen species measurements 
ROS measurements were performed in stimulated mouse and human neutrophils by fluorescent 
detection of ROS activity using flow cytometry as previously described.
23 
Briefly, 2 × 10
6
/ml 
neutrophils or eosinophils were resuspended in medium, and 100 l of cell suspension was pre-
incubated in the presence and absence of different inhibitors for 30 min, before priming with 25 ng/ml 
GM-CSF for 20 min. Cells were then stimulated with 10
-8
 M C5a or 100 ng/ml LPS. As a control, we 
also stimulated neutrophils with 25 nM PMA for 15 min without GM-CSF priming. DHR123 was added 
to the cells at the final concentration of 1 µM. The reaction was stopped by adding 200 µl of ice-cold 
PBS, the ROS activity of the samples was measured immediately using flow cytometry (BD 
FACSCalibur) and quantified using FlowJo software (Ashland, OR, USA).  
 
Statistical analysis  
Mean values (± SEM) are provided. To compare groups, one-way ANOVA was applied. P values < 
0.05 were considered statistically significant. 
 
Results 
 
Atg5-knockout mouse eosinophils are able to release extracellular DNA  
To investigate whether Atg5-knockout mouse eosinophils are capable of forming 
ETs, eosinophils were isolated from IL5tg_Atg5eoΔ and control IL5tg_Atg5flox/flox mice, 
primed for 20 min with GM-CSF and subsequently activated with C5a or LPS, or 
alternatively, with PMA in the absence of priming, all known triggers of EET 
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formation.24 Atg5-knockout eosinophils were able to form EETs just as well as 
eosinophils from control IL5tg_Atg5flox/flox mice (Fig. 1a). Eosinophils of IL5tg_Atg5eoΔ 
mice displayed a complete ATG5 knockout at the protein level and exhibited strongly 
reduced autophagic activity as assessed by p62 accumulation and reduced LC3-II 
expression (Fig. 1b). 
To quantify the extracellular DNA scaffolds of EETs formed by activated 
mouse eosinophils, we collected culture supernatants and measured the amount of 
released dsDNA using PicoGreen fluorescent dye.23 As expected, there were large 
statistically significant differences in dsDNA release between unstimulated and 
activated eosinophils whether derived from control or from IL5tg_Atg5eoΔ mice (Fig. 
1c). However, we observed no differences in the dsDNA release between activated 
Atg5-knockout and control mouse eosinophils (Fig. 1c).  
Pharmacological inhibitors of autophagy, namely CQ and Baf A1, exhibited no 
effect on EET formation, whereas other inhibitors, such as 3-MA and wortmannin, 
blocking both class I and class III PI3Ks, prevented EET formation and significantly 
reduced the amount of dsDNA release. Rapamycin, known to stimulate autophagy, 
had no effect on EET formation in either control or Atg5-knockout mouse eosinophils 
(Fig. 1a and 1c). In control experiments, we observed an increased autophagic flux 
following exposure to rapamycin and a reduced autophagic flux as a consequence of 
3-MA or wortmannin treatment. Moreover, CQ and Baf A1 treatment resulted in an 
accumulation of LC3-II (data not shown). 
Moreover, Atg5-knockout and control eosinophils were able to generate the 
same amounts of ROS (Fig. 1d), which is known to be required for EET formation.24 
Taken together, these data suggest that ROS production and DNA release by mouse 
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eosinophils are independent of ATG5 expression and autophagy, but, as expected, 
do require class I PI3K activity. 
 
Atg5-knockout mouse neutrophils are able to release extracellular DNA  
To investigate whether the formation of NETs is also independent of ATG5, mouse 
neutrophils were isolated from Atg5NΔ and control Lyz2Cre/Cre mice and primed for 20 
min with GM-CSF and subsequently activated with C5a or LPS, or alternatively, with 
PMA in the absence of priming, all known triggers of NET formation.17 Atg5-knockout 
neutrophils were able to form NETs just as well as neutrophils isolated from control 
Lyz2flox/flox mice (Fig. 2a). Neutrophils of Atg5NΔ mice exhibited no detectable ATG5 
expression as well as strongly reduced autophagic activity as assessed by p62 
accumulation and LC3-II expression (Fig. 2b).19 
 
As in the eosinophil system, we also quantified the dsDNA release between 
Atg5-knockout and control mouse neutrophils. There were large statistically 
significant differences in dsDNA release between unstimulated and activated 
neutrophils whether derived from control or from Atg5NΔ mice (Fig. 2c). However, we 
observed no differences in the dsDNA release between activated Atg5-knockout and 
control mouse neutrophils (Fig. 2c). The two pharmacological inhibitors of autophagy 
CQ and Baf A1 exhibited no effect on NET formation, whereas 3-MA and 
wortmannin prevented NET formation and significantly reduced the amount of 
dsDNA release. Furthermore, rapamycin, which stimulates autophagy, had no effect 
on NET formation (Fig. 2a and 2c).  
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Moreover, Atg5-knockout neutrophils were able to generate the same 
amounts of ROS as controls (Fig. 2d), known to be required for NET formation.17 In 
should be noted, that neutrophils from older WT mice (9 to 10 months old) also 
exhibited no defect in ROS production or NET formation (data not shown). Taken 
together, silencing the Atg5 gene in mouse eosinophils and neutrophils resulted in 
autophagy-deficient cells. However, both Atg5-knockouts were able to produce the 
same amounts of ROS and ETs as the corresponding wild-type granulocytes. 
 
Pharmacological inhibitors of autophagy do not prevent EET formation by 
human eosinophils 
Since mouse and human eosinophils differ in some functional responses, we also 
performed experiments with human eosinophils. To trigger EET formation, we 
stimulated human eosinophils in the same two ways as mouse eosinophils. We 
defined the formation of EETs by demonstrating the presence of extracellular DNA 
fibers associated with granule proteins.24 3-MA and wortmannin completely 
abrogated EET formation upon physiological activation with GM-CSF and C5a or 
after exposure to low concentrations of PMA (Fig. 3a). In contrast, Baf A1 and 
rapamycin had no effect as could be confirmed by quantitative assessment of the 
released DNA (Fig. 3b). These results indicate that the PI3K inhibitors 3-MA and 
wortmannin affect EET formation as a consequence of diminished ROS production 
and not because of blocked autophagy. Indeed, 3-MA and wortmannin abrogated the 
ability of human eosinophils to produce ROS upon activation, while ROS production 
was not affected by CQ, Baf A1 or rapamycin (Fig. 3c). 
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Pharmacological inhibitors of autophagy do not prevent NET formation by 
human neutrophils 
We also performed experiments in the human neutrophil system and stimulated NET 
formation in the same way as in mouse neutrophils. We defined the formation of 
NETs by demonstrating the presence of extracellular DNA fibers associated with 
released elastase.17 The results were similar to those seen in the eosinophil system: 
3-MA and wortmannin completely blocked NET formation upon physiological 
activation of neutrophils with GM-CSF and C5a or after exposure to low 
concentrations of PMA. In contrast, CQ, Baf A1, and rapamycin had no effect on 
NET formation (Fig. 4a). These data were confirmed by quantification of dsDNA 
release (Fig. 4b). Also, as with eosinophils, the ROS data showed that CQ, Baf A1, 
and rapamycin had no effect, while the PI3K inhibitors 3-MA and wortmannin 
completely blocked ROS production (Fig. 4c).  
 
Discussion 
Previously published work pointed to the possibility that NET formation required 
autophagy.4,5,9 It should be noted that these studies used pharmacological inhibitors 
to block class III PI3K in order to block the initiation of autophagosome formation. 
However, it is probable that these inhibitors have additional targets resulting in an 
indirect inhibition of NET formation. Moreover, rapamycin, a drug which can induce 
autophagy has revealed contrasting results in different studies regarding its influence 
on NET formation.7,8 In a recent study, it was suggested that neutrophils from older 
mice exhibit decreased expression levels of ATG5 and reduced levels of autophagy. 
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Such neutrophils also had a reduced capacity to generate NETs and the authors 
implied that autophagy could regulated NET formation.9 
In this study, in order to verify such previous findings, we silenced the Atg5 
gene in both mouse eosinophils and neutrophils. While we have described the 
generation of Atg5NΔ mice previously,19 this is the first report in which Atg5 was 
specifically deleted in eosinophils. Clearly, the Atg5eoΔ mice will be valuable tools to 
dissect the role of autophagy in eosinophils in future studies. Silencing of Atg5 was 
followed by the loss of ATG5 protein and reduced levels of autophagy in both 
granulocyte types. In contrast to the previously published work, however, our data 
suggest that lack of ATG5 does not influence the formation of ETs in either mouse 
eosinophils or neutrophils.  
Both EET and NET formation depend on the activation of the NADPH 
oxidase,17,24 which requires type I PI3K activity.14 GM-CSF treatment followed by 
C5a stimulation activates type I PI3K and NADPH activities.13,25,26 Consequently, 
pharmacological inhibitors targeting type I PI3K will block ROS production and ET 
formation in both eosinophils and neutrophils. Since wortmannin and 3-MA not only 
block type III, but also type I PI3K activity, the conclusion that autophagy is required 
for the formation of ETs is unwarranted. In fact, our study supports the assumption 
that these agents block EET and NET formation by blocking type I PI3K activity. This 
view is further supported by the lack of any effect after treatment with 
pharmacological inhibitors (CQ and Baf A1) and activators (rapamycin) of 
autophagy. 
Taken together, this report indicates that neither mature eosinophils nor 
neutrophils have a requirement for autophagy for EET and NET formation. The 
strength of our study is that we have obtained the same data in both mouse and 
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human cells and that we have used both genetic and pharmacological approaches. 
Future work will be required to determine which granulocyte functions depend on 
autophagy. 
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Figure legends 
Figure 1. The formation of mouse EETs is independent of ATG5 and autophagy. 
Mature mouse eosinophils were isolated from bone marrow of IL5tg_Atg5flox/flox and 
IL5tg_Atg5eoΔ mice. (a) Released DNA (MitoSOX, red), indicated by an arrow, and 
nuclear DNA stained with Hoechst 33342 (blue), were assessed by confocal 
microscopy. Bars, 10 µM. (b) Eosinophils from control or IL5tg_Atg5eoΔ mice were 
analyzed for protein expression of ATG5, p62, LC3 and GAPDH. Results are 
representative of at least three independent experiments. (c) Quantification of 
dsDNA in supernatants of non-activated and activated eosinophils using PicoGreen 
fluorescent dye. (d) Total ROS activity was assessed by DHR123 fluorescence and 
flow cytometric analysis. All data are presented as means ± SEM of at least 3 
independent experiments.  **p<0.01; ***p<0.001. 
Figure 2. The formation of mouse NETs is independent of ATG5 and autophagy. 
Mature mouse neutrophils were isolated from bone marrow of Lyz2Cre/Cre as control 
and Atg5NΔ mice. (a) Released DNA (MitoSOX, red), indicated by an arrow, and 
nuclear DNA stained with Hoechst 33342 (blue), were assessed by confocal 
microscopy. Bars, 10 µM. (b) Neutrophils from control or Atg5NΔ mice were analyzed 
for protein expression of ATG5, p62, LC3 and GAPDH. Results are representative of 
at least three independent experiments. (c) Quantification of dsDNA in supernatants 
of non-activated and activated neutrophils using PicoGreen fluorescent dye. (d) Total 
ROS activity was assessed by DHR123 fluorescence and flow cytometric analysis. 
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All data are presented as means ± SEM of at least 3 independent experiments.  
***p<0.001. 
Figure 3. The formation of human EETs is autophagy-independent. Human blood 
eosinophils were isolated from healthy donors by negative selection using antibody 
conjugated magnetic beads. (a) EET formation, indicated by an arrow, following 
short-term stimulation (total 45 min) of human eosinophils with the indicated triggers 
in the presence and absence of CQ (10 µM), Baf A1 (250 nM), 3-MA (5 mM), 
wortmannin (100 nM) or rapamycin (1 µM), was assessed by confocal microscopy. 
Extracellular eosinophil peroxidase (green) together with released DNA (PI, red) is 
shown outside the cells. Bars, 10 µM. (b) Quantification of dsDNA in supernatants of 
activated eosinophils using PicoGreen fluorescent dye. (c) Total ROS activity was 
assessed by DHR123 fluorescence and flow cytometric analysis. All data are 
presented as means ± SEM of at least 3 independent experiments.  ***p<0.001; 
****p<0.0001. 
Figure 4. The formation of human NETs is autophagy-independent. Human blood 
neutrophils were isolated from healthy donors by Ficoll-Hypaque centrifugation. (a) 
NET formation, indicated by an arrow, following short-term stimulation (total 45 min) 
of human neutrophils with the indicated triggers in the presence and absence of CQ 
(10 µM), Baf A1 (250 nM), 3-MA (5 mM), wortmannin (100 nM) or rapamycin (1 µM), 
was assessed by confocal microscopy. Extracellular neutrophil elastase (green) 
together with released DNA (PI, red) is shown outside the cells. Bars, 10 µM. (b) 
Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen 
fluorescent dye. (c) Total ROS activity was assessed by DHR123 fluorescence and 
flow cytometric analysis. All data are presented as means ± SEM of at least 3 
independent experiments.  *p<0.05; ***p<0.001; ****p<0.0001. 
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